Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-21

FDA Approved: TOLVAPTAN — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approves an original generic application for tolvaptan from Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tolvaptan (tolvaptan)

Snippet

ORIG AP for TOLVAPTAN (TOLVAPTAN)